HBM Holdings (HKG:2142) unit Nona Biosciences developed HCAbLM, a language model trained on fully human heavy-chain-only antibodies (HCAbs).
The model, the first of its kind globally, is designed to capture the unique sequence characteristics of fully human HCAbs, according to the report.
The study, entitled "A foundation model learns the sequence and functional grammar of fully human heavy-chain-only antibodies," was published on bioRxiv.